QS Investors’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
FLAM
RSCM
PAMP
QS Investors's XENT Position: Q2 2021 in Review
QS Investors reduced its Intersect ENT, Inc (XENT) stake by 1.8% in Q2 2021, selling an estimated $3.74K and leaving 11,000 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #1072.
QS Investors first reported a position in XENT in Q3 2015 and has held it in 24 quarters since. The position peaked at $2.45M in Q1 2018. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.
- QS Investors held 11,000 shares of Intersect ENT, Inc worth $188K as of Q2 2021.
- QS Investors sold 200 Intersect ENT, Inc shares in Q2 2021, an estimated $3.74K.
- Intersect ENT, Inc made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #1072 holding.
- QS Investors first reported a position in Intersect ENT, Inc in Q3 2015 and has held it in 24 quarters since.
- QS Investors's Intersect ENT, Inc position peaked at $2.45M in Q1 2018.
- 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.